• News

    Megan Pace Joins Moderna as Chief Corporate Affairs Officer

    Learn More >

  • News

    Newly Published Data Highlight Moderna's mRNA Platform in Advancing Prophylactic Vaccine for Cytomegalovirus (CMV) Infections

    Learn More >

  • News

    Moderna Closes $500 Million Equity Financing

    Learn More >

  • News

    Moderna Announces an Array of Clinical Advances and Outlines 2018 Priorities; 19 Development Candidates, including 10 Clinical Programs, Highlight Productivity of mRNA Platform

    Learn More >

  • News

    Dr. John Mendlein Joins Moderna as President, Corporate and Product Strategy

    Learn More >

  • News

    Moderna Publishes Preclinical Data in Cell Reports on mRNA Therapeutic to Treat Rare Liver Disease

    Learn More >

  • News

    Moderna Announces First-in-Human Dosing for Phase 1 Study of Personalized Cancer Vaccine

    Learn More >

What is mRNA?

Messenger RNA, or mRNA, plays a vital role in human biology. mRNA is a molecule that carries genetic code from DNA in a cell’s nucleus to ribosomes, the cell’s protein-making machinery.

An mRNA technology company

Moderna is a technology company designed to maximize the promise of mRNA science.  Learn about the components of our mRNA platform, why mRNA is like software, and how our ecosystem is fueling our progress.

A modality-focused pipeline

Our modalities are technological solution sets that we can deploy to create a family of medicines for different diseases within one therapeutic area, and often across therapeutic areas.

Mission-driven and committed

We’re not just about doing cool science.  We come to work every day to make mRNA medicines a reality for patients.  We are driven by our mission, and committed to impacting people’s lives and enhancing human health globally.